RHUMBLINE ADVISERS - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 173 filers reported holding KURA ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$1,011,176
-9.5%
110,876
+5.0%
0.00%0.0%
Q2 2023$1,117,417
+87747.2%
105,616
+1.6%
0.00%
-50.0%
Q1 2023$1,272
+1.8%
104,003
+3.3%
0.00%0.0%
Q4 2022$1,250
-99.9%
100,703
+2.4%
0.00%0.0%
Q3 2022$1,343,000
-20.0%
98,324
+7.4%
0.00%0.0%
Q2 2022$1,679,000
+25.1%
91,591
+9.7%
0.00%0.0%
Q1 2022$1,342,000
+5.8%
83,485
-7.9%
0.00%0.0%
Q4 2021$1,269,000
-26.1%
90,616
-1.2%
0.00%0.0%
Q3 2021$1,718,000
-7.2%
91,740
+3.3%
0.00%0.0%
Q2 2021$1,852,000
-3.1%
88,840
+31.4%
0.00%
-33.3%
Q1 2021$1,911,000
-16.5%
67,592
-3.6%
0.00%0.0%
Q4 2020$2,289,000
+18.6%
70,090
+11.3%
0.00%0.0%
Q3 2020$1,930,000
+66.0%
62,999
-11.7%
0.00%
+50.0%
Q2 2020$1,163,000
+174.9%
71,359
+68.0%
0.00%
+100.0%
Q1 2020$423,000
-27.1%
42,481
+0.7%
0.00%0.0%
Q4 2019$580,000
-5.5%
42,200
+4.3%
0.00%0.0%
Q3 2019$614,000
-17.6%
40,461
+7.0%
0.00%0.0%
Q2 2019$745,000
+23.8%
37,812
+4.1%
0.00%0.0%
Q1 2019$602,000
+15.5%
36,309
-2.2%
0.00%0.0%
Q4 2018$521,000
+27.7%
37,118
+59.1%
0.00%0.0%
Q3 2018$408,000
-5.1%
23,337
-1.3%
0.00%0.0%
Q2 2018$430,000
+26.8%
23,647
+30.7%
0.00%0.0%
Q1 2018$339,000
+59.2%
18,095
+29.9%
0.00%
Q4 2017$213,000
-4.1%
13,935
-6.1%
0.00%
Q3 2017$222,000
+69.5%
14,845
+5.3%
0.00%
Q2 2017$131,00014,0990.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 3,766,852$57,633,0006.49%
GREAT POINT PARTNERS LLC 2,197,283$33,618,0005.74%
Sio Capital Management, LLC 392,027$5,998,0003.38%
BVF INC/IL 1,353,846$20,714,0002.50%
Boxer Capital, LLC 844,789$12,925,0002.36%
ALETHEA CAPITAL MANAGEMENT, LLC 89,673$1,372,0002.18%
Minerva Advisors LLC 170,921$2,607,0001.41%
NEXTHERA CAPITAL LP 445,550$6,817,0001.26%
DAFNA Capital Management LLC 117,281$1,794,0000.97%
PFM Health Sciences, LP 1,752,124$26,807,0000.64%
View complete list of KURA ONCOLOGY INC shareholders